A detailed history of Lynwood Capital Management Inc. transactions in Immix Biopharma, Inc. stock. As of the latest transaction made, Lynwood Capital Management Inc. holds 405,000 shares of IMMX stock, worth $911,250. This represents 11.13% of its overall portfolio holdings.

Number of Shares
405,000
Holding current value
$911,250
% of portfolio
11.13%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$2.64 - $6.68 $1.07 Million - $2.71 Million
405,000 New
405,000 $1.24 Million
Q2 2023

Aug 14, 2023

BUY
$1.6 - $2.9 $320,400 - $580,725
200,250 New
200,250 $538,000
Q4 2022

Feb 07, 2023

BUY
$0.75 - $2.43 $18,750 - $60,750
25,000 New
25,000 $58,000
Q1 2022

May 05, 2022

SELL
$1.86 - $6.75 $1.05 Million - $3.82 Million
-565,297 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$2.95 - $4.0 $1.67 Million - $2.26 Million
565,297 New
565,297 $2.01 Million

Others Institutions Holding IMMX

About Immix Biopharma, Inc.


  • Ticker IMMX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,910,100
  • Market Cap $31.3M
  • Description
  • Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in developing various tissue-specific therapeutics in oncology and inflammation in the United States and Australia. The company is developing IMX-110 that is in Phase 1b/2a clinical trials for the treatment of soft tissue sarcoma and solid tumors; IMX-111, a tissue-specif...
More about IMMX
Track This Portfolio

Track Lynwood Capital Management Inc. Portfolio

Follow Lynwood Capital Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lynwood Capital Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Lynwood Capital Management Inc. with notifications on news.